Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Transplant Proc ; 38(5): 1625-33, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16797371

RESUMO

We proposed to evaluate differences between recipient's immune response to vascularized skin and combined vascularized skin/bone allografts, under a 7-day alphabeta-TCR plus cyclosporine (CsA) treatment protocol. Thirty-six transplantations were performed in six groups: group I (isograft control-vascularized skin graft; n=6); group II (isograft control-combined vascularized skin/bone graft; n=6); group III (allograft rejection control group-vascularized skin graft; n=6); group IV (allograft rejection control-combined vascularized skin/bone graft; n=6); group V (allograft treatment-vascularized skin graft; n=6); and group VI (allograft treatment-combined vascularized skin/bone graft; n=6). Isograft transplantations were performed between Lewis rats and allografts were transplanted across the MHC barrier from Brown Norway to Lewis rats. In the allograft treatment group, a combined alphabeta-TCR+CsA protocol was applied for 7 days. All groups were compared clinically, immunologically and histologically. Statistical significance was determined with two-tailed Student's t test. Indefinite graft survival was achieved in the isograft control group (>300 days). Allograft rejection controls rejected within 5 to 9 days posttransplant; chimerism levels were undetectable (<.5%). Allografts under the alphabeta-TCR+CsA protocol had significantly extended survival when skin was combined with bone (61-125 days) compared to vascularized skin allografts (43-61 days). Lymphoid macrochimerism was significantly higher in group VI than group V. Histology confirmed skin and bone viability. Combined vascularized skin/bone allografts had higher and sustained levels of donor-specific chimerism and extended allograft survival.


Assuntos
Células da Medula Óssea/citologia , Células da Medula Óssea/imunologia , Transplante Ósseo/imunologia , Complexo Principal de Histocompatibilidade , Transplante de Pele/imunologia , Quimeras de Transplante , Animais , Ciclosporina/uso terapêutico , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/patologia , Sobrevivência de Enxerto/imunologia , Teste de Histocompatibilidade , Imunossupressores/uso terapêutico , Modelos Animais , Ratos , Ratos Endogâmicos BN , Ratos Endogâmicos Lew , Células-Tronco/imunologia , Doadores de Tecidos , Coleta de Tecidos e Órgãos/métodos , Transplante Homólogo/imunologia , Transplante Isogênico/imunologia
2.
Acta Chir Plast ; 47(2): 45-6, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16033151

RESUMO

In this report, the advantages of temporarily maintained posterior paraneurium and external epineurium are presented during indirect nerve repair with a nerve graft. By using this technique, it is possible to overcome the retraction of the proximal and distal nerve stumps. In addition, an accurate prediction for the required length of nerve graft can be made and an optimal coaptation can be performed easily since the alignment of the fascicles is maintained.


Assuntos
Neuroma/cirurgia , Nervo Sural/transplante , Humanos , Procedimentos de Cirurgia Plástica/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA